米国 武田勝利

武田薬品工業がジェネリック製薬会社2社を訴えていた裁判の控訴審でCAFCは連邦地裁の判断を支持し、被告2社に原告の弁護士費用を負担するデシジョンを下したとのことです。
ホームページでのニュースリリース
Orange Book Blog

Panel Upholds $17M Attorney Fee Award, Cites Bad-Faith Patent Litigation by Drug Companies
　Marcia Coyle
　The National Law Journal
　December 9, 2008
A three-judge panel of the U.S. Court of Appeals for the Federal Circuit on Monday upheld an attorney fee award of nearly $17 million because of baseless filings and bad faith patent litigation by two drug companies.

A district court awarded the fees to Takeda Chemical Industries, which had sued two generic drug companies -- Mylan Laboratories and Alphapharm Pty. Ltd. -- for patent infringement. ..(more)